During endochondral bone formation, chondrocytes in the cartilaginous anlage of long bones progress through a spatially and temporally regulated differentiation program before being replaced by bone. To understand this process, we have characterized the differentiation program and analyzed the relationship between chondrocytes and their extracellular environment in the regulation of the program. Our results indicate that, within an epiphyseal growth plate, the zone of proliferating chondrocytes is not contiguous with the zone of hypertrophic chondrocytes identified by the transcription of the type X collagen gene. We find that the postproliferative chondrocytes which make up the zone between the zones of proliferation and hypertrophy specifically transcribe the gene for cartilage matrix protein (CMP). This zone has been termed the zone of maturation. The identification of this unique population of chondrocytes demonstrates that the chondrocyte differentiation program consists of at least three stages. CMP translation products are present in the matrix surrounding the nonproliferative chondrocytes of both the zones of maturation and hypertrophy. Thus, CMP is a marker for postmitotic chondrocytes. As a result of the changes in gene expression during the differentiation program, chondrocytes in each zone reside in an extracellular matrix with a unique macromolecular composition. Chondrocytes in primary cell culture can proceed through the same differentiation program as they do in the cartilaginous rudiments. In culture, a wave of differentiation begins in the center of a colony and spreads to its periphery. The cessation of proliferation coincides with the appearance of CMP and eventually the cells undergo hypertrophy and synthesize type X collagen. These results reveal distinct switches at the proliferative-maturation transition and at the maturation-hypertrophy transition during chondrocyte differentiation and indicate that chondrocytes synthesize new matrix molecules and thus modify their preexisting microenvironment as differentiation progresses. However, when ''terminally'' differentiated hypertrophic chondrocytes are released from their surrounding environment and incubated in pellet culture, they stop type X collagen synthesis, resume proliferation, and reinitiate aggrecan synthesis. Eventually they cease proliferation and reinitiate CMP synthesis and finally type X collagen. Thus they are capable of recapitulating all three stages of the differentiation program in vitro. The data suggest a high degree of plasticity in the chondrocyte differentiation program and demonstrate that the progression and maintenance of this program is regulated, at least in part, by the extracellular environment which surrounds a differentiating chondrocyte during endochondral bone formation. ᭧ 1995 Academic Press, Inc.
INTRODUCTION
cursor cells differentiate into chondrocytes of the cartilaginous growth plate and they progress through a chondrocyte differentiation program, starting as proliferating chondroCartilaginous rudiments of a developing embryo serve as cytes and ending up as hypertrophic chondrocytes. The hyanlagen from which long bones are formed during endopertrophic chondrocytes are then removed and replaced by chondral bone formation. During this process the length bone. The chondrocyte differentiation program has been and shape of a bone is determined. Limb mesodermal prepartitioned into different stages based on cell shape and volume, biosynthetic and metabolic activities, and, most accurately, on molecular markers. At least two models have 1988) the differentiation program is divided into two stages gå rd, 1981). It contains two homologous repeats (CMP-like domains) that are separated by an EGF-like domain (Arand the chondrocytes are considered to be either in the proliferative or in the hypertrophic state. Thus, this model graves et al., 1987; Kiss et al., 1989) . CMP-like domains have also been found in collagen types VI, VII, XII, and XIV; proposes that the proliferative stage immediately precedes the hypertrophic stage during endochondral bone formavon Willebrand factor; complement factors B and C2; the a chains of the integrins Mac-1, p150/95, LFA-1, and VLA-2; tion. The proliferating chondrocytes synthesize type II collagen and aggrecan (Miller, 1972; Doege et al., 1990) . These malaria thrombospondin-related anonymous protein; dihydropyridine-sensitive calcium channel; and inter-a-trypsin markers distinguish the chondrocytes from their mesodermal precursors which synthesize type I collagen. The hyperinhibitor (Winterbottom et al., 1992; Yamagata et al., 1991; Gerecke et al., 1993; Parente et al., 1991 ; Bork and Rohde, trophic chondrocytes produce type X collagen, a hypertrophic cartilage-specific molecule (Schmid and Conrad, 1982; . In the matrix of cartilage, CMP interacts with collagen fibrils (Winterbottom et al., 1992) and proteoglycans Capasso et al., 1984) . The second model proposes that the chondrocytes of the growth plate are divided into three dis- (Paulsson and Heinegå rd, 1979) . The collagen binding of CMP has been localized to the CMP domains. Thus, it has tinct stages that are identified histologically as the zones of proliferation (zone 1), maturation (zone 2), and hypertrophy been suggested that CMP may be involved in collagen fibrillogenesis and in the organization of the matrix of carti-(zone 3) (Kim and Conrad, 1977; Stocum et al., 1979) . According to this model, the transition of the chondrocytes lage (Tondravi et al., 1993) .
The results of the present study indicate that the CMP from the zone of proliferation to the zone of hypertrophy would be separated by an additional developmental stage, gene is transcribed only in the postproliferative chondrocytes in a zone between the zones of proliferation and hyperthe stage of maturation. However, no specific molecular markers have been identified for chondrocytes in this stage.
trophy of the growth plate. CMP translation products are present in the matrix surrounding the nonproliferative The molecular markers that characterize the differentiated state of chondrocytes are extracellular matrix (ECM) chondrocytes of both the zones of maturation and hypertrophy. Thus, CMP is a marker for postmitotic chondrocytes. macromolecules and the chondrocyte differentiation process is modulated by extracellular cues including the ECM As a result of the changes in gene expression during the differentiation program, chondrocytes in each zone reside (Benya and Schaffer, 1982; von der Mark et al., 1992b) . In monolayer culture, chondrocytes which are seeded at low in an extracellular matrix with a unique macromolecular composition. Chondrocytes in cell culture proceed through density will transform their chondrogenic phenotype (round shape, type II collagen synthesis) to a fibroblastic one (flatthe same temporal progression of proliferation, maturation, and hypertrophy in that CMP is produced by postproliferatened morphology, type I collagen synthesis) under certain conditions (von der Mark et al., 1977) . This transformation tive chondrocytes before type X collagen is synthesized. Finally, hypertrophic chondrocytes that are released from depends on cell shape and attachment, which is mediated through cell-matrix interaction (Benya and Schaffer, 1982) . their surrounding environment are capable of recapitulating all three stages of the differentiation program in vitro. The alteration of the chondrocyte differentiation process also occurs in vivo. For example, articular cartilage normally does not undergo endochondral bone formation. However, in the osteoarthritic articular cartilage where the
MATERIALS AND METHODS
matrix is destroyed, chondrocytes resume proliferation and type X collagen, a hallmark of cartilage hypertrophy, is syn-
Cell and Organ Culture
thesized (von der Mark et al., 1992b) . Thus, hypertrophy of chondrocytes is reinitiated (Hoyland et al., 1991) . It is unPrimary cultures of chondrocytes were established as described by Schmid and Conrad (1982) . Briefly, tibiotarsi clear what determines chondrocytes to undergo regeneration, dedifferentiation, or hypertrophy (von der Mark et al., were dissected from stage 41 (15th day of incubation) chick embryos (Hamburger and Hamilton, 1951) . The bone shell 1992a).
There are three major types of ECM molecules in cartiand the tarsus region were separated from the cartilaginous growth plate and discarded. To ensure that the selected relage: collagens, proteoglycans, and noncollagenous glycoproteins. That these macromolecules play an important gions of chondrocytes were derived from the desired zone, only cells at the center of any one zone were used for cell morphogenetic role during endochondral bone formation is demonstrated most strikingly by the analysis of mutations or pellet culture. The cells at the boundary with neighboring zones were discarded. In addition, control experiments were which alter the expression of the genes of aggrecan core (Argraves et al., 1981; Goetinck, 1991) and collagens type carried out by immunostaining with mAbs, to ensure that a cartilage piece was only positive for the molecular marker II (Bogaert et al., 1992; Garofalo et al., 1991 Garofalo et al., , 1993 Metsaranta et al., 1992) , type IX (Nakata et al., 1993) , and type X that is characteristic for chondrocytes of the desired zone. For organ culture, cartilage explants are cultured in Ham (Jacenko et al., 1993) . As part of this study we investigated the gene expression of cartilage matrix protein (CMP) during F-12 medium containing 10% fetal calf serum (plating medium) (Gibco, Grand Island, NY) at 37ЊC in an atmosphere endochondral bone formation. CMP is a major noncollagenous protein in the matrix of cartilage (Paulsson and Heine- of 5% CO2 . For monolayer cell culture and pellet mass culture, a piece of cartilage from a defined zone was subthe tissue. Different labeling time periods were tested. One hour was the minimum time for intensive labeling. For cell jected to enzymatic treatment with 0.1% trypsin (Sigma, St. Louis, MO), 0.3% collagenase (Worthington, Freehold, culture labeling, BrdU (1 mM) is added to cell culture 1 hr before immunostaining. NJ), and 0.1% type I testicular hyaluronidase (Sigma) (dissociation medium). After an incubation of 30 min at 37ЊC this dissociation medium was removed and replaced with fresh Immunocytochemistry and Histochemistry dissociation medium and incubated at 37ЊC for an additional hour. For monolayer cell culture, chondrocytes were Tissue embedding, processing for cryostat sectioning, and indirect immunofluorescence for immunocytochemical resuspended in plating medium containing 0.01% testicular hyaluronidase. After culturing overnight, the medium of analyses were performed as described by Fitch et al. (1982) . For double immunofluorescence staining, cultured cells the chondrocytes was replaced with fresh medium without hyaluronidase. The medium was changed every other day.
were fixed at 020ЊC with 70% ethanol, 50 mM glycine, pH 2.0, for 20 min. Slides were then washed with phosphatePellet mass cultures were performed as described by Kato et al. (1988) . Briefly, chondrocytes were washed and pelleted buffered saline (PBS) and incubated with primary antibodies. After washing with PBS, secondary antibodies were apat 1000g in a 15-ml plastic centrifuge tube and incubated in plating medium at 37ЊC.
plied together with Hoechst nuclear dye. Slides were washed and mounted in 95% glycerol in PBS. Double or triple exposure photography was performed with a micro-
Determination of DNA Content
scope from Nikon. The monoclonal antibody against CMP, 1H1/E2, was DNA content from organ or pellet mass cultures was determined as described by Labarca and Paigen (Labarca and generated as described in detail by Binette et al. (1994 al., 1982) , and a helical determinant in type X collagen (X-AC9; Schmid and Linsenmayer, 1985) . The mAb against
In Situ Hybridization
BrdU was purchased from Boehringer-Mannheim. The polyclonal antibodies (RC1) were generated in rabbit In situ hybridization for mRNAs encoding aggrecan core protein, link protein, CMP, and type X collagen were peragainst purified chicken CMP. They were characterized by both ELISA and Western blot analysis as recognizing formed according to Hayashi et al. (1986) and . The slides were viewed by dark-field and CMP specifically. Affinity-purified rhodamine or fluorescein-conjugated secondary antibody was purchased bright-field optics and photographed on a Microphot-FXA microscope from Nikon (Melville, NY). The probe for CMP from Jackson ImmunoResearch (West Grove, PA). was CMP 1 (Argraves et al., 1987) . The probe for aggrecan core protein was PG 525 (Stirpe et al., 1987) . The link pro-
Western Blot Analysis
tein probe was LPG2 (Deá k et al., 1986) . The type X collagen probe was a PstI/PvuII fragment of pYN 3116 (Ninomiya et Chick sterna were homogenized in 4 M urea, 50 mM Tris at pH 7.5. The homogenate was centrifuged and the amount al., 1986).
of protein in the supernatant was measured by the optical density of the sample at 280 nm. Five micrograms of each
BrdU Incorporation and Detection
supernatant were analyzed on a discontinuous 8% SDS-PAGE. The proteins were transferred onto ImmobilonIncorporation and detection of BrdU in cartilage tissues were performed with the 5-bromo-2-deoxyuridine labeling PVDF membrane (Millipore Corp., Bedford, MA) in 25 mM Tris, 192 mM glycine, 15% methanol. The membranes were and detection kit II from Boehringer-Mannheim (Indianapolis, IN). Labeling cartilage with BrdU was carried out in ovo blocked in 2% bovine serum albumin fraction V (Sigma) in PBS for 30 min and then probed with the anti-CMP or in vitro. Both methods gave identical results. For in ovo labeling, 40 ml of BrdU (1 ml/g of body weight) were injected mAb1H1/E2, or with a polyclonal Ab EM 77 against type X collagen ( Pacifici et al., 1991) . Horseradish peroxidaseinto the aircell of an egg 3 hr before dissection. For in vitro tissue labeling, a tibiotarsus was dissected out of the embryconjugated goat anti-mouse IgG (H / L) or anti-rabbit IgG (Bio-Rad Lab, Melville, NY) was used as a secondary antionic chick leg. Perichondrium and bone shell were then peeled from the cartilage to ensure penetration of BrdU into body. Visualization of the immunoreactive proteins was achieved using the ECL Western blotting detection reagents (Amersham Corp., Heights, IL) and exposing the membrane to Kodak X-Omat AR film.
RESULTS

The CMP Gene Is Transcribed Only by Chondrocytes of the Zone of Maturation
To identify different stages in the chondrocyte differentiation program, we used the incorporation of BrdU to visualize proliferating chondrocytes, and probes that allowed the determination of the transcriptional activity of a number of genes that encode ECM molecules. A bright-field histological section of a growth plate of a stage 41 embryo is shown in Fig. 1A . Histologically identifiable zones are indicated. Incorporation of BrdU by the nuclei identifies the zone of proliferation (P) at the distal end of the tibia (Fig.  1B) . Chondrocytes in this region (zone 1) are small and round, with many mitotic figures in the nuclei (Fig. 2, 1 ). In the zone of hypertrophy (zone 3), the size of the cells is dramatically increased (Fig. 2, 3 ). This zone (H) is characterized by the presence of the mRNA for type X collagen ( Fig.  1F ), a hypertrophic cartilage-specific molecule (Schmid and Linsenmayer, 1983) . A comparison of Figs. 1B and 1F indicates that the proliferative zone is not contiguous with the hypertrophic zone. Therefore, there exists an additional zone between the zones of proliferation and hypertrophy. This zone corresponds to the histologically identified zone of maturation (Kim and Conrad, 1977; Stocum et al., 1979) and the CMP gene is transcribed only by chondrocytes in this zone (M) (Fig. 1C) . Flattened cells at the beginning of this zone (2a) give rise to medium-sized cells toward the end of the zone (2b), fulfilling the transition from the proliferating to the hypertrophic state (see Figs. 1A and 2, 2a and 2b) . Transcripts for aggrecan core protein and link protein The Translation Product of the CMP Gene Is a (Fig. 3A) . Proliferating cells of the blood or bone marrow
Marker for Postproliferative Chondrocytes
could also be identified (Fig. 3A, white arrows) . CMP could be shown by immunofluorescence to be present in the two The distribution of ECM proteins and incorporated BrdU was examined in sections from the tibiotarsus of a stage 45 postproliferative zones of maturation and hypertrophy as well as in the tarsus (Fig. 3C) . CMP is absent not only from chick embryo. BrdU labeling (Fig. 3A) revealed a zone of proliferating chondrocytes in the epiphyseal growth plate.
the proliferative zone, but also from the proliferating chondrocytes at the perimeter of the tibia (compare Figs. 3C and At this stage the proliferative zone is shorter than the one at stage 41 (compare Figs. 3A and 1B) . There are many prolif-3A). Type X collagen was present only in the hypertrophic zone (Fig. 3D) . In contrast to the specific localization of erating chondrocytes at the perimeter of the growth plate, (1), first half of the mature zone (2a), second half of the mature zone (2b), and the hypertrophic zone (3) in vivo or the explant from the proliferative zone incubated in culture for 1 hr (1h), 20 hr (1d), and 5 days (5d). All the sections are stained with hematoxylin and eosin. Arrows in (1) indicate dividing chondrocytes. Bar, 10 mm.
CMP and type X collagen, link protein was detected
Spatial and Temporal Expression of the throughout the growth plate (Fig. 3B) . Both CMP and link
Differentiation Program in Primary Chondrocyte
protein were present in the matrix surrounding chondro-
Cultures cytes of the hypertrophic region even though the genes for
To test whether the spatial organization of chondrocytes these proteins are not transcribed by the chondrocytes of into distinct zones in vivo reflects the manifestation of their that zone (Figs. 3C and 3B) . Thus, the translation product differentiation process temporally, we examined the differof the CMP gene is a marker for nonproliferating chondroentiation time sequence of chondrocytes in monolayer cell cytes of either the mature or the hypertrophic zone. These culture. Chondrocytes were isolated from the core of the results indicate that the synthetic repertoire of chondroproliferative zone of tibiae from stage 41 chick embryos and cytes changes as differentiation proceeds and, as a result, the cultured. After 3 days of culture, CMP can be detected in composition of matrix is modified during the progression of the differentiation program.
the cultures, but only in a subset of the chondrocytes. The CMP-positive cells are located at the center of the colonies extracellular space as filamentous material throughout the colonies (Fig. 4D) . At this time, type X collagen can be detected (Fig. 4A) . The cells at the periphery of the colonies do not stain for CMP. The CMP distribution pattern is in contrast as punctate fluorescence signals within the colonies. Thus, in the culture system, the chondrocytes go through the same difto that of type II collagen, which can be detected in the cells throughout the colonies (Fig. 4B) . To test whether the ferentiation program as they do in vivo. A wave of differentiation spreads from the center of the colonies to the periphery CMP-negative cells at the periphery are in fact the proliferating chondrocytes, the cultures were incubated in the presas proliferative cells differentiate into mature and subsequently into hypertrophic chondrocytes. ence of BrdU for 1 hr. The peripheral cells which lack CMP actively incorporate BrdU (Fig. 4C ), indicating that they are proliferating chondrocytes. BrdU incorporation cannot be
Removal of the Extracellular Environment from detected in the chondrocytes at the center of the colonies
Proliferative Chondrocytes Prolongs Their
which produce CMP (Fig. 4C) , indicating that these are post-
Proliferation and Delays Their Maturation proliferative cells. After 15 days of incubation, chondrocytes have stopped dividing, as indicated by the lack of BrdU
The data presented above suggest that there is a correlation between the state of differentiation of chondrocytes incorporation (data not shown). CMP is laid down in the FIG. 5 . Diagram describing the method used to generate differentiation stage-specific organ cultures and pellet mass cultures. P, proliferative zone; M, mature zone; H, hypertrophic zone. These three zones were separated by microdissection. The cartilage explants were either directly incubated as organ cultures or digested with collagenase, testicular hyaluronidase, and trypsin to eliminate the extracellular environment. These chondrocytes were washed and pelleted and incubated as pellet cell cultures. The proliferative zone and the hypertrophic zone were tested in this experiment.
and their ECM expression. To test if this state is directly as proliferating chondrocytes (Fig. 7A ). There is little staining for the postmitotic chondrocyte marker CMP at the end influenced by the extracellular environment surrounding differentiating chondrocytes, an in vitro culture system was of the first hour (Fig. 7B) , and there is no staining for type X collagen (data not shown). However, after 1 day of incubadevised in which pieces of cartilage are taken from the core of the zones of proliferation and hypertrophy (Fig. 5) . In one tion (20 hr), there is strong staining for CMP (Fig. 7D) , no detectable BrdU incorporation (Fig. 7C) , and still no staining set of experiments the chondrocytes are maintained as an isolated piece of cartilage surrounded by their original extrafor type X collagen (data not shown). These changes suggest that the chondrocytes have differentiated to the stage of cellular matrix (organ culture). These are compared with the chondrocytes that are enzymatically removed from their maturation. Type X collagen can be first detected at the 3rd day of incubation (data not shown). After 5 days of incubasurrounding matrix and cultured as a pellet mass culture (pellet culture). The organ and pellet cultures were carried tion, type X collagen can be detected throughout the cultured piece (Fig. 7F ) and there is no BrdU incorporation out with chondrocytes that originated from the same region of the growth plate. For each comparison, therefore, the detected (Fig. 7E) , indicating that the chondrocytes have reached the hypertrophic stage. The results also suggest that chondrocytes are from the same developmental stage.
When a piece of cartilage from the proliferative zone is the constant level of DNA in the cultured pieces of cartilage is the result of the maintenance of living cells and not the maintained as an organ culture in the presence of serum the DNA content remains constant during 12 days of incuresult of a balance between proliferation and cell death. In contrast, in organ cultures without serum, DNA content in bation (Fig. 6, solid squares) . This observation indicates that the chondrocytes have stopped proliferating in culture. The the cultured pieces decreases by 50% during incubation (Fig.  6, solid diamonds) . However, in these cultures the chondromorphology of the chondrocytes of the cartilaginous pieces cultured for 1 hr, 1 day, or 5 days is very similar to that cytes go through the same differentiation sequence as the cells cultured in the presence of serum (data not shown). seen in the mature (zones 2a and 2b) and the hypertrophic (zone 3) zones, respectively (compare Fig. 2, 1h to 2a, 1d to Therefore, in organ culture, serum is necessary for preventing cell death or tissue degradation, but not required 2b, and 5d to 3). These changes in morphology suggest that the chondrocytes have undergone differentiation in culture.
for chondrocyte differentiation.
To compare quantitatively the appearance of CMP and This rapid process of differentiation in vitro from the proliferative through the mature to the hypertrophic stage was type X collagen during incubation of the cartilage explants from the proliferative zone, an equal amount of extracts (5 demonstrated at the molecular level by the incorporation of BrdU (marker for proliferation) and the expression of CMP mg) from cartilage explants cultured for 0, 1, and 5 days are analyzed by Western blot. As shown in Fig. 7G , a band of (marker for maturation) and type X collagen (marker for hypertrophy) (Fig. 7) . The incorporation of BrdU by the cells CMP trimers (200 kDa) is barely detectable at the beginning of incubation (0 day). It is clearly detected after 1 day of during the first hour of incubation confirms their identity incubation and is present at the 5th day of incubation. In program, we examined, by in situ hybridization, the expression of the genes encoding aggrecan core protein and CMP comparison, type X collagen (59 kDa) is not detected at either 0 or 1 day of incubation, but is detected at the 5th during the incubation of the chondrocytes in pellet cultures. These two genes are not active in hypertrophic chondroday of incubation. Thus, when chondrocytes from the proliferative zone are cultured as an organ, proliferation ceases cytes (Figs. 9A and 9B). At Day 4 of incubation, the transcription of the genes for aggrecan core protein and CMP is and differentiation starts during the 1st day of incubation. In contrast, in pellet mass cultures of proliferative chondroreinitiated throughout the pellet mass culture derived from the hypertrophic zone (Figs. 9D and 9E ). The presence of cytes that are removed from their extracellular environment, proliferation continues for 10 days (Fig. 6, open transcripts for aggrecan core protein is still present at Day 7 (Fig. 9G ) and the transcription of CMP seems to reach a square). These chondrocytes synthesize a new surrounding matrix (data not shown) before undergoing subsequent matpeak at this time. Both the density and intensity of the grains for CMP (hybridization signals) increase (Fig. 9H ). uration and hypertrophy. Therefore, the transient removal of the extracellular environment from proliferating cells in This suggests that there is an elevation in the transcriptional activity of the CMP gene by an increased number of situ prolongs the proliferative period and delays the progression of the differentiation program.
cells. There is no longer any increase in DNA content (Fig.  8 , open squares) at this time. In contrast, the transcription of the type X collagen gene, a marker for hypertrophic cartilage Hypertrophic Chondrocytes Can Recapitulate the (Fig. 9C) , is greatly down-regulated at 4 days of incubation
Chondrocyte Differentiation Program
( Fig. 9F) . At Day 12 of incubation, the expression for type X collagen is reinitiated (Fig. 9I) . The histochemical staining The behavior of postmitotic, ''terminally'' differentiated hypertrophic chondrocytes was examined in organ and in of a Day 12 pellet mass culture shows the de novo synthesized matrix material that is deposited between the cells pellet mass cultures. Pieces of hypertrophic cartilage were taken from the core of late hypertrophic zones. Chondroby the chondrocytes during the incubation period (Fig. 9J , arrow). cytes in these pieces are large in size (see Fig. 2 ) and they actively transcribe the type X collagen gene (Fig. 9C) . To
The sections of the pellet cultures and organ cultures of hypertrophic chondrocytes were examined by immunoeliminate the complication of cell death, hypertrophic chondrocytes were incubated only in serum containing mestaining with mAbs against incorporated BrdU and type X collagen. At Day 4 of incubation, there are many BrdUdium. In organ culture, the DNA content of the incubated pieces of hypertrophic cartilage remains constant (Fig. 8, positive nuclei in the pellet culture (Fig. 10A) and none in the organ culture (Fig. 10C) . However, at Day 7 of incubasolid squares). However, in pellet mass cultures, the postmitotic hypertrophic chondrocytes that were deprived of their tion, there are only a few BrdU-positive nuclei in the pellet culture ( Fig. 10E ) and still none in the organ culture ( Fig.  extracellular surrounding in situ resume proliferation and double their DNA content by 6 days (Fig. 8, open squares) . 10G). These results confirm the measurement of DNA content in both pellet and organ cultures (Fig. 8) . Furthermore, To determine if the resumption of proliferation represents the beginning of the recapitulation of the differentiation type X collagen is distributed throughout both pellet and content and incorporation of BrdU), maturation (CMP expression), and hypertrophy (type X expression).
DISCUSSION
The Cellular Organization of the Growth Plate
The chondrocytes of the growth plate progress through a differentiation program which can be partitioned into a number of stages. These stages are clearly reflected in the spatial organization of the chondrocytes in the different zones of the growth plate. The generally accepted model, as presented in many textbooks (Ross and Romrell, 1989; Gilbert, 1994) , describes the proliferative zone in a growth plate as immediately preceding the hypertrophic zone. Our study clearly shows that, at least in chick embryos, this is not the case. The distribution of proliferating chondrocytes in a growth plate was determined by monitoring the localization of BrdU incorporated by dividing chondrocytes at the G1-S phase transition. The zone of hypertrophic chondrocytes was identified by the expression of type X collagen, a commonly accepted marker of hypertrophic chondrocytes (Schmid and Linsenmayer, 1983) . Our results clearly indicate that the proliferating chondrocytes make up a zone which is not contiguous with the hypertrophic zone. Therefore, there exists a population of nonproliferating chondrocytes that are not yet hypertrophic. Here we identify the transcription of the CMP gene as a molecular marker for chondrocytes of that zone. Our observations are consistent with a second model which proposes that the chondrocytes Oohira et al., 1974) . The zones that we identify type X collagen (F). (G) Western blot analysis of expression of CMP and type X collagen by cartilage explants of the proliferative zone cultured for 0, 1, and 5 days. Each lane contains 5 mg of protein from extracts of cultured cartilage explants.
organ cultures (Figs. 10B, 10D , 10F, and 10H). Since transcripts for type X collagen are present in the hypertrophic chondrocytes at the beginning of incubation (Fig. 9C) , but are not detected in the pellet cultures at Day 4 of incubation (Fig. 9F) , type X collagen in the matrix of the pellet cultures at Day 4 must have been synthesized by the cells which are type X collagen mRNA-positive at the beginning of the incubation. This confirms the cells in the pellet culture which are capable of proliferation as hypertrophic chondro- by reinitiating the stages of proliferation (increase of DNA ther by determining the pattern of transcription of genes that encode chondrocyte matrix molecules. Our report is the first to identify CMP as a product of and a marker for mature chondrocytes. A restricted pattern of expression of the CMP gene in the growth plate has also been reported in human and mouse (Aszó di et al., 1994; Mundlos and Zabel, 1994) . However, in both reports it is assumed that the proliferative zone is contiguous with the hypertrophic zone, and the zone of proliferation was not identified experimentally in either study. In human embryonic long bones the mRNA for CMP was reported to be present in the upper ''hypertrophic'' and lower ''proliferative'' zone (Mundlos and Zabel, 1994) . This region is likely to correspond with the zone of maturation as defined in the present study. In another report (Aszó di et al., 1994 ) the expression of a chicken genomic clone was monitored by immunohistochemical means in transgenic mice. High levels of chicken CMP were reported to be present in the zone of proliferating chondrocytes and not in the zone of hypertrophic chondrocytes. It is difficult to compare the interpretation of these results with those of the present study since the proliferating chondrocytes were not identified in the transgenic animals. The reported absence of the translation product of the chicken CMP gene in the hypertrophic zone of the transgenic mice differs from our observation (Chen et al., unpublished) that mouse CMP is present in the hypertrophic region of normal mice.
It has been reported that CMP is not detected in the superficial layer of chondrocytes covering the joint articular surface (Franzen et al., 1987; Mundlos and Zabel, 1994) , but is detected in the deep layer of articular cartilage ous results (Stirpe and Goetinck, 1989) tion). Therefore, CMP contributes to the formation of the program. When chondrocytes undergo hypertrophy, the genes that encode CMP, link protein, and aggrecan core protein are cartilage matrix established by postproliferative chondrocytes, before the matrix is further modified by type X collarepressed and the gene for type X collagen is activated. This represents the third switch in the program. These three gen synthesized by hypertrophic chondrocytes. These results indicate that the properties of the cartilage matrix switches represent key transition points in chondrogenesis and endochondral bone formation. The first switch separates change during the course of differentiation. Furthermore, this modification of the matrix is controlled, at least in chondrocytes from their mesodermal precursors and the second switch separates proliferating chondrocytes from postmipart, at the mRNA level. This is illustrated by the in situ hybridization data of the exclusive synthesis of mRNA for totic mature chondrocytes. In the ''permanent'' cartilage such as articular cartilage and the cartilage of the caudal portion of CMP by mature chondrocytes and of mRNA for type X by hypertrophic chondrocytes. the sternum, chondrocyte differentiation stops at the maturation stage. If the third switch is activated, chondrocytes proThe program of chondrocyte differentiation is summarized in Fig. 11 . When chondrogenesis is initiated, the genes for ceed to the hypertrophic stage. Therefore, this switch separates the permanent cartilage from the transitional cartilage collagens type II (Miller, 1972) and IX , aggrecan core protein, and link protein (Figs. 1D and which serves as a model for endochondral bone formation. 1E) are activated and the gene for type I collagen is repressed (Linsenmayer et al., 1973) . The switch from mesodermal pre-
The Chondrocyte Differentiation Program cursor cells to proliferating chondrocytes is the first step in
Is Reversible
the cartilage differentiation program. The gene for CMP is activated when chondrocytes stop proliferating and undergo
In the present study we also show that the chondrocyte differentiation program is dynamic. It can be delayed, rematuration. This step represents the second switch in the 
